how much bpc-157 to take orally can be taken or subcutaneously, and for most people the BPC 157 Dosages: A Complete
Description
In cases of recurrence, a repeat course of Dodex therapy may be initiated
Each claim coded with E55.9 must be supported by lab evidence and treatment documentationnot just diagnosis notes
And then repeat the same cycle every six to 12 months
I am hesitant to take the second shot, but still considering and looking for more data apart from the two papers listed this article
Critical Safety Considerations BPC-157 has not received approval from Health Canada or the US FDA for human therapeutic use
